Lilly’s Pill Foundayo Gets EU Nod for Obesity and Diabetes
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Eli Lilly & Co.’s Foundayo won the backing of a key European regulatory panel, putting the weight-loss pill in line for approval in additional major markets.
This approval marks a significant step for Lilly as it seeks to expand the availability of Foundayo across Europe.
Eli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Eli Lilly & Co.’s Foundayo won the backing of a key European regulatory panel, putting the weight-loss pill in line for approval in additional major markets.”
Bloomberg — Lilly’s Pill Foundayo Gets EU Nod for Obesity and Diabetes